Fig. 1From: Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexedDistribution of non-small-cell lung cancer patients. Distribution of non-small-cell lung cancer patients arranged in order of the duration of pemetrexed therapy. The dotted lines indicate the cutoff for the top 5 % and bottom 12 % of patientsBack to article page